{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Financial Desk", "lead_paragraph": "A small distributor plans to sell an extremely expensive drug treatment that could help thousands of psychotic patients for a price 30 percent below that set by the drug's maker. Homecare Management, based in Ronkonkoma, L.I., said it is ready to distribute the drug, clozapine, under safeguards required by Sandoz Ltd., the Swiss company that makes the medication, at a price of $6,300 to $6,800 for a year's supply for an average dose, depending on the amount prescribed. Robert Clifton, a Homecare Management vice president, said the price would cover the drug and monitoring for potentially dangerous side effects, which will include a national system of blood testing by the SmithKline Beecham Company's Clinical Laboratories unit.", "headline": {"main": "A Plan to Undersell Sandoz on Drug for Schizophrenia"}, "abstract": null, "print_page": "37", "word_count": 740, "_id": "4fd1a91b8eb7c8105d6c5a06", "snippet": "A small distributor plans to sell an extremely expensive drug treatment that could help thousands of psychotic patients for a price 30 percent below that set by the drug's maker.    Homecare Management, based in Ronkonkoma, L.I., said it is ready to...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/04/27/business/a-plan-to-undersell-sandoz-on-drug-for-schizophrenia.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "SANDOZ LTD"}, {"name": "organizations", "value": "HOMECARE MANAGEMENT"}, {"name": "organizations", "value": "CLINICAL LABORATORIES"}, {"name": "organizations", "value": "SMITHKLINE BEECHAM CO"}, {"name": "subject", "value": "MEDICAID (TITLE XIX OF FED MEDICARE LEGISLATION)"}, {"name": "subject", "value": "PRICES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "CLOZAPINE (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "1991-04-27T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 1, "offset": 0, "time": 43}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}